Group A
No moderate or severe events in the past year, with CAT/CAAT <10 or mMRC 0–1.
GOLD 2027 assessment framework
Calculate the GOLD 1–4 airflow obstruction grade and A/B/E group from post-bronchodilator spirometry, symptoms, and exacerbations over the past year.
For adults with clinician-confirmed COPD. Values are processed in your browser, without patient identifiers.
Enter the assessment to see the GOLD airflow grade and A/B/E group, with the reasoning for each.
Based on the GOLD 2027 assessment framework. Input values are not rounded before classification. Treatment decisions require a complete clinical review, including current therapy and response.
Often called COPD stages, these grades describe the degree of airflow obstruction. Apply them to post-bronchodilator FEV₁ percent predicted when the ratio is below 0.70 and COPD has been clinically established. GOLD assessment table
| Grade | Airflow obstruction | FEV₁ (% predicted) |
|---|---|---|
| GOLD 1 | Mild | FEV₁ ≥80% predicted |
| GOLD 2 | Moderate | 50% ≤ FEV₁ <80% predicted |
| GOLD 3 | Severe | 30% ≤ FEV₁ <50% predicted |
| GOLD 4 | Very severe | FEV₁ <30% predicted |
Percent predicted = measured FEV₁ ÷ predicted FEV₁ × 100. Use the reference values on the report or review the GLI spirometry calculator.
ABE grouping adds symptom burden and recent exacerbation history. It is assessed separately from the airflow grade. GOLD 2027 ABE criteria
No moderate or severe events in the past year, with CAT/CAAT <10 or mMRC 0–1.
No moderate or severe events in the past year, with CAT/CAAT ≥10 or mMRC ≥2.
At least one moderate or severe event in the past year, at any symptom level.
With a post-bronchodilator ratio of 0.55, FEV₁ of 55% predicted, CAT/CAAT of 12, and no moderate or severe events, the result is GOLD 2 and group B. One moderate exacerbation changes the group to E, while the airflow grade remains 2.
The one-event threshold was introduced in GOLD 2026 and retained in 2027. A single moderate or severe exacerbation qualifies for group E. Older 2025 summaries used a different threshold, which can produce a different group. 2026 framework · 2027 framework
CAT has been renamed CAAT, with interchangeable scores. It measures broader health impact, while mMRC focuses on breathlessness. Select the completed assessment available in the record. If different instruments disagree, review the full symptom assessment rather than averaging their scores. GOLD symptom assessment
This tool withholds a COPD classification. A preserved ratio can coexist with symptoms or impaired lung function that warrant assessment. GOLD recommends repeat testing when confirming obstruction around the threshold, including ratios between 0.60 and 0.80. Spirometric diagnostic context
A classification summarizes selected assessment findings. Current treatment, response, comorbidities, exacerbation details, patient goals, and other clinical factors guide management. The BODE index calculator adds functional information, with its own prognostic limitations.
Implements GOLD 2027 classification criteria. Sources checked November 17, 2026. PulmTools provides an independent educational implementation.
Official source for the current COPD assessment framework.
Airflow grades and the symptom/exacerbation criteria for groups A, B, and E.
Diagnostic context, repeat spirometry, symptom instruments, and assessment limitations.
Prior edition introducing the one-event threshold retained in the 2027 ABE framework.